- Home
- SGMO vs BWMX Comparison
SGMO vs BWMX Comparison
Compare SGMO & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- BWMX
- Stock Information
- Founded
- SGMO 1995
- BWMX 1995
- Country
- SGMO United States
- BWMX Mexico
- Employees
- SGMO N/A
- BWMX N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- BWMX Catalog/Specialty Distribution
- Sector
- SGMO Health Care
- BWMX Consumer Discretionary
- Exchange
- SGMO Nasdaq
- BWMX Nasdaq
- Market Cap
- SGMO 488.2M
- BWMX 403.4M
- IPO Year
- SGMO 2000
- BWMX N/A
- Fundamental
- Price
- SGMO $1.13
- BWMX $11.51
- Analyst Decision
- SGMO Buy
- BWMX Strong Buy
- Analyst Count
- SGMO 5
- BWMX 1
- Target Price
- SGMO $5.20
- BWMX $22.50
- AVG Volume (30 Days)
- SGMO 10.5M
- BWMX 34.8K
- Earning Date
- SGMO 03-12-2025
- BWMX 02-20-2025
- Dividend Yield
- SGMO N/A
- BWMX 11.70%
- EPS Growth
- SGMO N/A
- BWMX N/A
- EPS
- SGMO N/A
- BWMX 1.21
- Revenue
- SGMO $52,291,000.00
- BWMX $700,821,742.00
- Revenue This Year
- SGMO N/A
- BWMX $9.30
- Revenue Next Year
- SGMO $5.97
- BWMX $6.59
- P/E Ratio
- SGMO N/A
- BWMX $8.93
- Revenue Growth
- SGMO N/A
- BWMX 6.88
- 52 Week Low
- SGMO $0.30
- BWMX $10.05
- 52 Week High
- SGMO $3.18
- BWMX $21.28
- Technical
- Relative Strength Index (RSI)
- SGMO 37.01
- BWMX 55.16
- Support Level
- SGMO $1.00
- BWMX $10.80
- Resistance Level
- SGMO $1.18
- BWMX $11.38
- Average True Range (ATR)
- SGMO 0.15
- BWMX 0.48
- MACD
- SGMO -0.04
- BWMX 0.11
- Stochastic Oscillator
- SGMO 13.84
- BWMX 90.97
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided into different categories based on the type of products it sells and includes, kitchen and food preservation, home solutions, bathroom, laundry & cleaning, tech and mobility, and bedroom and wellness products. The JAFRA's segment is divided into fragrance, color, skincare, and toiletries products. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.